A Prospective, Multi-site, Randomized, Sham-Controlled, Double-Blind Trial With One-Way Crossover Designed to Assess the Effectiveness and Safety of the Gimer NeuroBlock SCS Trialing System for the Treatment of Chronic Back Pain and/or Lower Limb Pain

NCT04693650 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pain
Low Back Pain
Lower Limb Pain

Interventions

DEVICE: NeuroBlock UHF stimulation

Sponsor

GiMer Medical